Dr. Antônio Novaes earned his PhD in Medicine (Nephrology) from the Federal University of São Paulo, Brazil, where his research focused on extracellular vesicles and their role in renal cell communication. He subsequently completed a postdoctoral fellowship at Stony Brook University, investigating the therapeutic potential of selective PPARγ modulators, including GQ-16, in models of rapidly progressive glomerulonephritis and focal segmental glomerulosclerosis. His work integrates molecular, cellular, and translational approaches to elucidate disease mechanisms and identify novel therapeutic strategies.
In November 2025, Dr. Novaes joined the Daehn Lab at Mount Sinai to investigate mechanisms of glomerular cell crosstalk in the pathogenesis of glomerular diseases.
Dr. Antônio Novaes earned his PhD in Medicine (Nephrology) from the Federal University of São Paulo, Brazil, where his research focused on extracellular vesicles and their role in renal cell communication. He subsequently completed a postdoctoral fellowship at Stony Brook University, investigating the therapeutic potential of selective PPARγ modulators, including GQ-16, in models of rapidly progressive glomerulonephritis and focal segmental glomerulosclerosis. His work integrates molecular, cellular, and translational approaches to elucidate disease mechanisms and identify novel therapeutic strategies.
In November 2025, Dr. Novaes joined the Daehn Lab at Mount Sinai to investigate mechanisms of glomerular cell crosstalk in the pathogenesis of glomerular diseases.